[Expression profile and prognostic significance of CD24, p53 and p21 in lymphomas. A tissue microarray study of over 600 non-Hodgkin lymphomas].
Went
P
P
Institut für Pathologie, Universität Basel, Schweiz.
Dellas
T
T
Bourgau
C
C
Maurer
R
R
Augustin
F
F
Tzankov
A
A
Dirnhofer
S
S
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015703:Antigens, CD / Q000032:analysis* / Q000235:genetics; D051927:CD24 Antigen; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000032:analysis* / Q000235:genetics; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis* / Q000401:mortality*; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis* / Q000235:genetics; D008875:Middle Aged; D015999:Multivariate Analysis; D011379:Prognosis; D016016:Proportional Hazards Models; D040081:Protein Array Analysis; D012189:Retrospective Studies; D016159:Tumor Suppressor Protein p53 / Q000032:analysis* / Q000235:genetics
D015703:Antigens, CD; D051927:CD24 Antigen; C497889:CD24 protein, human; C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D008562:Membrane Glycoproteins; D016159:Tumor Suppressor Protein p53
Expressionsmuster und prognostische Bedeutung von CD24, p53 und p21 in Lymphomen. Eine Gewebe-Mikroarray-Studie an über 600 Non-Hodgkin-Lymphomen.